Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

AC Immune S.A. (ACIU)

AC Immune S.A. (ACIU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 372,710
  • Shares Outstanding, K 72,653
  • Annual Sales, $ 16,460 K
  • Annual Income, $ -66,040 K
  • 60-Month Beta 0.77
  • Price/Sales 22.34
  • Price/Cash Flow N/A
  • Price/Book 1.88
Trade ACIU with:

Options Overview Details

View History
  • Implied Volatility 87.09%
  • Historical Volatility 77.40%
  • IV Percentile 17%
  • IV Rank 16.63%
  • IV High 191.66% on 02/11/21
  • IV Low 66.23% on 05/20/21
  • Put/Call Vol Ratio 9.50
  • Today's Volume 63
  • Volume Avg (30-Day) 511
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 475
  • Open Int (30-Day) 3,434

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 0.11
  • Number of Estimates 3
  • High Estimate 0.90
  • Low Estimate -0.33
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +136.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.92 +4.47%
on 11/30/21
8.14 -36.86%
on 11/09/21
-1.53 (-22.94%)
since 11/01/21
3-Month
4.92 +4.47%
on 11/30/21
8.14 -36.86%
on 11/09/21
-2.15 (-29.49%)
since 09/01/21
52-Week
4.81 +6.86%
on 12/10/20
12.61 -59.24%
on 08/31/21
-0.35 (-6.38%)
since 12/01/20

Most Recent Stories

More News
AC Immune Announces Interim Phase 1b/2a Data Showing that its ACI-35.030 Anti-pTau Alzheimer’s Vaccine Generates a Potent Immune Response

Observed strong induction of antibodies specific for pathological forms of Tau with ACI-35.030 treatment New data presented at 14th CTAD conference...

ACIU : 5.12 (-0.19%)
AC Immune Announces Late-Breaker Presentation by Genentech at CTAD on Phase 2 Lauriet Study of Semorinemab in Mild-to-Moderate Alzheimer’s Disease

Analysis of the broader mITT population is consistent with the previously reported success in meeting one of the two co-primary endpoints (ADAS-Cog11) with...

ACIU : 5.12 (-0.19%)
AC Immune (ACIU) Reports Q3 Loss, Misses Revenue Estimates

AC Immune (ACIU) delivered earnings and revenue surprises of 17.24% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

ACIU : 5.12 (-0.19%)
AC Immune: Q3 Earnings Snapshot

LAUSANNE, Switzerland (AP) _ AC Immune SA (ACIU) on Monday reported a loss of $17.3 million in its third quarter.

ACIU : 5.12 (-0.19%)
AC Immune Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Announced the first positive cognitive results for a Tau-targeting monoclonal antibody in mild-to-moderate Alzheimer’s disease Closed its strategic...

ACIU : 5.12 (-0.19%)
Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline

AC Immune (ACIU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ACIU : 5.12 (-0.19%)
AC Immune Extends Research Collaboration with University of Pennsylvania Focusing on the Pathogenic Protein TDP-43, a Major Driver of Neurodegenerative Diseases

LAUSANNE, Switzerland, Nov. 04, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a...

ACIU : 5.12 (-0.19%)
New Data on AC Immune’s Abeta and pTau Clinical Programs in Alzheimer’s Disease To Be Presented at CTAD 2021

LAUSANNE, Switzerland, Nov. 02, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision...

ACIU : 5.12 (-0.19%)
AC Immune Holds its Extraordinary General Meeting and Appoints Monica Shaw, M.D., and Prof. Monika Bütler, Dr. oec., to its Board of Directors

Dr. Shaw is a pharmaceutical industry expert who has been involved in advancing more than 15 therapeutic products from first-in-human studies through...

ACIU : 5.12 (-0.19%)
AC Immune to Present at the Jefferies London Healthcare Conference

LAUSANNE, Switzerland, Oct. 25, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision...

ACIU : 5.12 (-0.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta...

See More

Key Turning Points

3rd Resistance Point 5.66
2nd Resistance Point 5.47
1st Resistance Point 5.30
Last Price 5.12
1st Support Level 4.94
2nd Support Level 4.75
3rd Support Level 4.58

See More

52-Week High 12.61
Fibonacci 61.8% 9.63
Fibonacci 50% 8.71
Fibonacci 38.2% 7.79
Last Price 5.12
52-Week Low 4.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar